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Background: The genetic epidemiology of ischemic stroke remains relatively unstudied, and
information about the genetic epidemiology of ischemic stroke in populations with significant
minority representation is currently unavailable.
Methods: The Brain Attack Surveillance in Corpus Christi project (BASIC) is a population-based
stroke surveillance study conducted in the bi-ethnic community of Nueces County, Texas, USA.
Completed ischemic strokes were identified among patients 45 years or older seen at hospitals in
the county between January 1, 2000 – December 31, 2002. A random sample of ischemic stroke
patients underwent an in-person interview and detailed medical record abstraction (n = 400).
Outcomes, including initial stroke severity (NIH stroke scale), age at stroke onset, 90-day mortality
and functional outcome (modified Rankin scale ≥2), were studied for their association with family
history of stroke among a first degree relative using multivariable logistic and linear regression. A
chi-square test was used to test the association between family history of stroke and ischemic
stroke subtype.
Results: The study population was 53.0% Mexican American and 58.4% female. Median age was
73.2 years. Forty percent reported a family history of stroke among a first degree relative. Family
history of stroke was borderline significantly associated with stroke subtype (p = 0.0563). Family
history was associated with poor functional outcome in the multivariable model (OR = 1.87; 95%
CI: 1.14–3.09). Family history was not significantly related to initial stroke severity, age at stroke
onset, or 90-day mortality.
Conclusion: Family history of stroke was related to ischemic stroke subtype and to functional
status at discharge. More research is needed to understand whether stroke subtype would be a
useful selection criterion for genetic association studies and to hypothesize about a possible genetic
link to recovery following ischemic stroke.
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Data from different sources, including animal and family
history studies, suggest that genetic factors play a role in
ischemic stroke [1-4]. Despite the challenges associated
with studying the genetics of a heterogeneous disorder,
several polymorphisms have been identified for ischemic
stroke with small to modest effects [5]. Most recently,
researchers using data from an Icelandic population have
identified a locus on chromosome 5 thought to be associ-
ated with ischemic stroke in humans [6]. While the focus
has been on identifying genetic determinants of stroke
risk, many aspects of the genetic epidemiology of
ischemic stroke remain relatively unstudied. Aside from
the relationship between a positive family history of
stroke and stroke risk, aspects of ischemic stroke for which
genetic factors are plausible, such as stroke subtype, stroke
severity and stroke outcomes, have not been thoroughly
investigated.
Further, information about the genetic epidemiology of
ischemic stroke in populations with significant represen-
tation from minority groups, such as Hispanic Americans,
is currently unavailable. Differences in stroke risk, age at
onset of stroke and family history of stroke between His-
panics and non-Hispanic whites raise the possibility of
genetic differences by ethnicity [7,8]. The objective of this
study was to provide an overview of the relationship
between family history of stroke and the epidemiology of
ischemic stroke including associations with stroke sub-
type, age at stroke onset, stroke severity, mortality, and
functional status following stroke using data from a bi-
ethnic study population of ischemic stroke cases aged
greater than 44 years.
Methods
BASIC is a population-based stroke surveillance study
conducted in Nueces County, Texas, USA. Methods of the
Brain Attack Surveillance in Corpus Christi (BASIC)
Project have been reported [9]. Due to its distance from
Houston and San Antonio, investigation in Nueces
County allows for complete case capture for first medical
contact in acute stroke. The population size of the county
is 313,645, and 95% of the population resides within the
city of Corpus Christi. Non Hispanic whites (NHW) com-
prise 38% of the population, and Mexican Americans
(MA) comprise 56%.
Acute cerebrovascular events (completed ischemic
strokes, transient ischemic attacks, intracerebral hemor-
rhages (ICH), and subarachnoid hemorrhages (SAH))
were identified among patients 45 years and over who
were seen (including those seen in the emergency depart-
ment and not admitted) at one of the seven area hospitals
between January 1, 2000 through December 31, 2002
using active and passive surveillance methods. Cases that
did not present to a hospital were identified through a
simple random sample from 45 primary care physicians
from the community and four nursing homes, and from
all 11 neurologists practicing in the county. Cerebrovascu-
lar events were validated by fellowship-trained stroke neu-
rologists based on published criteria and blinded to
subjects' race-ethnicity and age [10]. Only ischemic
strokes were included in this study. For those individuals
with multiple ischemic strokes (n = 5) within the time
period, only the first was considered for this analysis.
Therefore, the final population for analysis incorporated
incident strokes as well as recurrent strokes that occurred
during the study time period, but was limited to one
stroke per individual.
Outcomes
For this analysis, five outcomes were studied for their pos-
sible association with family history of stroke as outlined
in Table 1. How each outcome was measured and defined
for this analysis is described below.
Interview methodology and family history data
A random sample comprising two-thirds of patients with
validated cerebrovascular events was asked to participate
in an in-person interview with the goal of achieving a 50%
sample of stroke cases. The response rate for interview was
84% [11]. The interview contained questions regarding
family history of stroke among first degree relatives (par-
ents, siblings, and children). Patients unable to answer
appropriately to a series of orientation questions asked
Table 1: Outcomes and end points investigated for possible associations with family history of stroke.
Outcome End Point
Ischemic stroke subtype TOAST criteria (large artery atherosclerosis, cardioembolism, small 
vessel occlusion, stroke of other determined etiology, and stroke of 
undetermined etiology) plus additional category of non-lacunar stroke of 
unknown etiology[13]
Age at stroke onset Continuous age
Initial stroke severity (NIHSS) Continuous NIHSS
Functional outcome (mRS) mRS ≤1 vs mRS >1
Mortality Death ≤ 90 days vs Alive at 90 days
NIHSS = NIH stroke scale, mRS = modified Rankin scalePage 2 of 8
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of the patient whenever possible. Proxy interviews were
conducted with the person who knew the patient's daily
activities and medical history the most. A previous analy-
sis revealed the agreement between patient/proxy inter-
views for six critical elements (insurance status, use of a
routine physician, history of hypertension, history of dia-
betes, current smoking status, educational level, and trust
in doctors and nurses) ranged from 84% to 100%. Inter-
views were performed in English or Spanish depending on
the patients' language preferences.
A random sample of the patients interviewed was selected
to undergo a more detailed medical record abstraction,
including reports of medical testing performed and infor-
mation necessary to classify ischemic strokes according to
subtype. The random sample with both interview data
and detailed medical record abstraction was used for this
analysis.
Ascertainment of outcomes
Ischemic stroke cases were classified by two fellowship-
trained stroke neurologists into five stroke subtype catego-
ries according to the criteria of the Trial of ORG 10172 in
Acute Stroke Treatment (TOAST) Study: large artery
atherosclerosis, cardioembolism, small vessel occlusion,
stroke of other determined etiology, and stroke of unde-
termined etiology [12]. An additional category of non-lac-
unar stroke of unknown etiology was developed that
comprised large strokes that had insufficient evidence for
categorization into large artery atherosclerosis or cardi-
oembolism [13]. The inter-rater agreement between the
two neurologists for determination of subtype was high
(kappa 0.80, p < 0.001). Neurologists were blinded to the
subject's ethnicity and age.
Initial stroke severity was measured using the NIH stroke
scale (NIHSS). The NIHSS was retrospectively abstracted
from the chart in accordance with the validated method of
Williams et al [14]. Functional outcome was assessed at
discharge using a modified Rankin scale (mRS) calculated
by the abstractors using data in the medical record. For the
purposes of this analysis, the mRS, which ranges from 0–
6, was dichotomized to represent good (0–1) and poor
(2–6) functional outcome. This categorization of the mRS
has been shown to be more powerful than other choices
for cut points for this scale [15].
Deaths among the stroke cases were identified for the time
period January 1, 2000 through December 31, 2003 by
four methods: 1) surveillance of hospitalized or emer-
gency department stroke cases, 2) Texas Department of
Health (TDH), 3) Social Security Death Index (SSDI), and
4) Nueces County coroner. If a stroke case died in-hospi-
tal, the death was recorded by the abstractors during sur-
veillance. Otherwise, deaths were captured using methods
2–4 above. TDH provided death certificates for Texas res-
idents electronically, with a one-year lag period to ensure
complete capture. Demographic data from the medical
record, including first name, last name, social security
number, date of birth, and permanent address, was
crossed-referenced with the TDH death certificate data-
base. At least three of the five items must have been iden-
tical for the BASIC stroke case to be considered a match
Table 2: Demographics and risk factors for ischemic stroke cases with complete family history data (n = 353).
Family History
Yes (n = 158) No (n = 195)
N % n % p-value
MA 90 57.0 97 49.7 0.1773
NHW 68 43.0 98 50.3
Females 108 68.4 98 50.3 0.0006
Males 50 31.7 97 49.7
Risk Factors
Hypertension 120 76.0 138 70.8 0.2759
Diabetes 76 48.1 80 41.0 0.1838
Atrial Fibrillation 18 11.4 26 13.3 0.5836
Coronary Heart
Disease
51 32.3 71 36.4 0.4423
Hyperlipidemia 25 15.8 44 22.6 0.1128
Smoking 40 25.3 60 30.8 0.2589
History of Stroke/TIA 62 39.2 66 33.9 0.2952
MA = Mexican American, NHW = non-Hispanic whitePage 3 of 8
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ture deaths that occurred outside of Texas and not cap-
tured by TDH, we linked cases not identified as having
died using the first two data sources to the SSDI. We also
routinely screened records from the coroner. All deaths
reported to the coroner have a death certificate filed with
TDH.
Statistical analysis
Frequencies and percents were calculated for categorical
variables. Means and medians were calculated for contin-
uous variables. A chi-square test was used to test the asso-
ciation between family history of stroke among a first
degree relative and ischemic stroke subtype. Multivariable
logistic regression was used to test the association
between a positive family history of stroke among a first
degree relative and functional outcome (dichotomized
mRS) and 90-day mortality. Covariates were selected for
inclusion in the models in a pre-specified fashion based
on their plausible relationship with the given outcome or
their ability to confound family history. In each logistic
model, the number of covariates was limited based on the
rule of 10 which requires at least 10 least frequent out-
comes for each degree of freedom [16]. For the model pre-
dicting functional outcome the following covariates were
included: age, gender, ethnicity, hypertension, diabetes,
atrial fibrillation, coronary heart disease, NIHSS, and
stroke subtype. For the model predicting 90-day mortal-
ity, the following covariates were included: age, gender,
ethnicity, and NIHSS.
Multivariable linear regression was used to test the associ-
ation between a positive family history of stroke among a
first degree relative and initial stroke severity (NIHSS) and
age at stroke onset. Again, covariates were selected for
inclusion in the models in a pre-specified fashion. For the
models predicting NIHSS and age at stroke onset the fol-
lowing covariates were included: gender, ethnicity, hyper-
tension, diabetes, atrial fibrillation, coronary heart
disease, high cholesterol, smoking, and stroke subtype.
Age was also included in the model for NIHSS.
Family history was modeled dichotomously in all models
(yes/no). Ethnicity (MA vs. NHW), gender (female vs.
male) and the history variables (smoking, high choles-
terol, coronary artery disease, diabetes, atrial fibrillation,
hypertension) were treated dichotomously. Age was
treated continuously. Stroke subtype was modeled as a
series of indicator variables with cardioembolic strokes as
the referent.
Chi-square tests were used to test the association between
use of proxy subjects and family history and to compare
the demographic characteristics of cases with and without
proxies. To assess whether the use of proxy subjects con-
founded the relationship between family history and the
five outcomes, a covariate representing proxy subject (yes/
no) was also added to each of the multivariable models
and the degree to which the point or parameter estimate
changed was evaluated. A greater than 10% change was
considered to represent confounding. A chi-square test
was used to test the association between use of proxy sub-
jects and stroke subtype.
The project was approved by the Institutional Review
Boards at the University of Texas, Houston and University
of Michigan, and each Nueces County hospital.
Table 3: Distribution of ischemic stroke subtypes by family history (n = 353).
Family History
Ischemic Stroke Subtype Yes No
n % n %
Cardioembolic 37 23.4 32 16.4
Large vessel 16 10.1 35 18.0
Non-lacunar/large stroke* 34 21.5 44 22.6
Small vessel 39 24.7 33 16.9
Undetermined 29 18.4 49 25.1
Other 3 1.9 2 1.0
Total 158 100.0 195 100.0
χ2 (df 5) = 10.76, p = 0.0563
* Non-lacunar strokes of unknown etiology comprised of large strokes with insufficient evidence for categorization into large artery atherosclerosis 
or cardioembolismPage 4 of 8
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There were 2,550 validated cerebrovascular events
between January 1, 2000 and December 31, 2002.
Ischemic strokes constituted 1,477 of the 2,550 events.
One-hundred six cases who were not MA or NHW (7
Asian, 89 African American, 10 unknown race/ethnicity)
were excluded due to small sample size. Eight-hundred
seventeen of these cases were interviewed and 405 of the
cases were subtyped based on documentation gathered
during the extended medical record abstraction. Five
recurrent events were eliminated resulting in 400 ischemic
stroke cases for the final analysis.
Of the 400 cases interviewed, 39.5% reported a positive
family history of stroke among a first degree relative.
Eleven percent (n = 44) were unsure of a family history of
stroke and for three cases (0.8%), this question was not
answered. Table 2 displays baseline characteristics for
stroke subjects with complete family history data (n =
353). The study population was 53.0% (n = 187) MA and
58.4% (n = 206) female. Median age was 73.2 years (IQR:
65.2–79.7). There were no differences in the prevalence of
stroke risk factors among those with and without a posi-
tive family history of stroke. Women were more likely to
report a family history of stroke compared with men as we
have previously reported [8].
The distribution of ischemic stroke subtype among the
400 cases was 21.0% cardioembolic, 14.3% large vessel,
19.3% small vessel, 22.8% large strokes with insufficient
evidence for categorization into large artery atherosclero-
sis or cardioembolism, 21.5% undetermined etiology,
and 1.3% other determined etiology. Family history of
stroke was borderline significantly associated with
ischemic stroke subtype (p = 0.0563), with family history
less frequent among those with large vessel strokes and
more frequent among those with small vessel disease
(Table 3).
Results from the multivariable logistic regression models
are displayed in Table 4. Among the 400 cases, 16.0%
died within 90 days. Among those with a positive family
history, 16.5% died within 90 days, and among those
with no history, 12.3% died. Family history showed a pos-
itive association with 90-day mortality (OR = 1.55, 95%
CI: 0.77–3.13), although this association did not reach
significance in the multivariable model.
Among the 353 cases with family history data, 61.5% had
a mRS ≥ 2. Sixty-nine percent of those with a positive fam-
ily history had poor functional outcome compared to
55.4% in those with no family history. Family history was
positively associated with poor functional outcome in the
multivariable model (OR = 1.87; 95% CI: 1.14–3.09)
adjusted for the other covariates.
Results from the multivariable linear regression models
are displayed in Table 5. Median age at stroke onset was
71.4 years among those with a family history and 73.9
years among those with no family history. Family history
was associated with a younger age at stroke onset in the
multivariable model (β = -1.38, standard error = 1.18),
but this relationship was not statistically significant.
Median NIHSS was 4 among those with a family history
and 3 among those with no family history. Results from
the multivariable model (Table 5) suggest a mean NIHSS
difference of 0.41 between those with and without a fam-
ily history, but this association did not reach significance.
Use of proxies
Thirty-seven percent (n = 147) of the interviews were con-
ducted with proxies. In 80.7%, the proxy subject was a
spouse (31.7%) or child (49.0%) of the patient. The use
of proxies varied with age of the stroke case (p < 0.0001).
Median age of cases with a proxy interview was 78.8 years
and median age of cases without a proxy interview was
69.6 years. Use of proxies did not differ by gender or eth-
nicity of the case.
Family history did not vary by use of proxy subjects (p =
0.7560). However, the use of a proxy did appear to con-
found the relationship between family history and age at
stroke onset as evidenced by the change in the parameter
Table 5: Association of family history of stroke with initial stroke 
severity and age at stroke onset (n = 353).
End Point β Std Error
NIH stroke scale1 0.41 0.72
Age at stroke onset2 -1.38 1.18
Std Error = standard error
1 Adjusted for age, gender, ethnicity, hypertension, diabetes, atrial 
fibrillation, coronary artery disease, high cholesterol, smoking, 
ischemic stroke subtype
2 Adjusted for gender, ethnicity, hypertension, diabetes, atrial 
fibrillation, coronary artery disease, high cholesterol, smoking, 
ischemic stroke subtype
Table 4: Association of family history of stroke with functional 
outcome and mortality (n = 353).
End Point OR 95% CI
Rankin ≥ 21 1.87 (1.14, 3.09)
90-day Mortality2 1.55 (0.77, 3.13)
OR = odds ratio, CI = confidence interval
1 Adjusted for age, gender, ethnicity, hypertension, diabetes, atrial 
fibrillation, coronary artery disease, initial stroke severity, ischemic 
stroke subtype
2 Adjusted for age, gender, ethnicity, initial stroke severityPage 5 of 8
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history remained insignificant (p = 0.2817) in this model
regardless of inclusion of the variable for proxy subject.
Use of proxy subjects was significantly related to stroke
subtype (p < 0.0001).
Discussion
In our study population of ischemic stroke cases, family
history of stroke among a first degree relative was associ-
ated with poor functional outcome, defined as a modified
Rankin scale score ≥ 2 at discharge, adjusted for initial
stroke severity and other potential confounders. The asso-
ciations of family history with initial stroke severity and
90-day mortality, although not significant, together with
the association with poor functional outcome at hospital
discharge, suggested family history was related to more
severe strokes among the cases. Initial stroke severity and
functional outcome are known to be highly correlated
and were significantly associated in our data [17,18]. Pos-
sible explanations for the lack of a significant association
of family history with initial stroke severity include
reduced power to detect a difference due to our sample
size and possible clustering or downward bias of NIHSS
score assignments due to the retrospective designation of
these scores. Familial factors that influence poor short-
term recovery after stroke could explain the finding of a
positive association of family history with poor functional
outcome at discharge and its lack of association with ini-
tial NIHSS. Additional large-scale studies are needed to
confirm our findings and to suggest a potential genetic
link with recovery after stroke.
There may be differences in genetic susceptibility to stroke
based on ischemic stroke subtype. We found a borderline
significant association with the distribution of subtype
and family history, with the data suggesting that cases
with small vessel disease were more likely to have a family
history of stroke. This result is consistent with results from
hospital-based studies of stroke cases and controls [19-
21]. Our data also suggested that cases with large vessel
disease were less likely to have a family history. Previous
studies have found a greater prevalence of family history
among those with large vessel disease [19-21]. In our
study population, large vessel disease was present in
14.3% of cases. This percent is less than other study pop-
ulations and perhaps contributes to our different findings.
We also had 21.5% of cases with undetermined etiology
possibly due to less extensive evaluation documentation
in community hospitals. There may also be a genetic sus-
ceptibility to the same stroke type in the case as that of the
family member [19], but we were unable to explore this
question as the stroke type of the family member is
unknown. First degree relatives with stroke who are par-
ents of the case are often deceased by the time of the off-
spring's stroke, adding to the challenge of classifying the
family members' stroke type.
Previous studies have found associations between family
history of stroke and earlier age at stroke onset [20,22]
suggesting age may be a useful selection criteria for future
ischemic stroke genetics studies. Our findings with regard
to age at stroke onset were in this direction but not signif-
icant after multivariable adjustment for confounders and
independent predictors.
Strengths of the current study include: 1) the population-
based design and ascertainment of all cases presenting for
medical attention to a hospital, including those seen in
the emergency department but not subsequently hospital-
ized, 2) the inclusion of ischemic strokes only, as not all
types of stroke are equally likely to be heritable, 3) the
detailed subtyping of ischemic strokes to allow for com-
parison of family history across subtypes, and 4) the
inclusion of a significant proportion of Mexican Ameri-
cans, a minority population with increased risk of stroke.
Further, we adjusted for potential confounding factors
including stroke risk factors, stroke severity, demograph-
ics and stroke subtype when sample size and the fre-
quency of the outcome permitted.
Some limitations of this study warrant discussion. Family
history data was based on self-report by stroke cases and
was not validated through source documentation or inter-
views with family members. We interviewed a proxy sub-
ject in lieu of a patient interview when the patient could
not answer a series of orientation questions. In the major-
ity of these cases (84%), the interview was with a spouse,
sibling, or child who would likely have knowledge of the
Table 6: Comparison of point/parameter estimates for family history before and after adjustment for use of proxy subjects (n = 353).
Original Model Model with Proxy
End Point OR/Parameter Estimate for Family History OR/Parameter Estimate for Family History
Rankin ≥ 2 1.87 1.90
90-day Mortality 1.55 1.49
NIH stroke scale 0.41 0.42
Age at stroke onset -1.38 -1.19Page 6 of 8
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appear to confound the relationship between family his-
tory and the outcomes with the exception of age at stroke
onset; however, family history remained an insignificant
predictor of age at stroke regardless of proxy use. Some
stroke cases were unaware of their family history (11%),
and this could have biased our findings regarding family
history; however, the effect is likely to be small. We did
not have data on family size, which may impact family
history of stroke, and were unable to account for this fac-
tor in our analysis. We also did not have information on
age of the first-degree relative at the time of the stroke.
Stroke subtypes were classified using data from abstracted
medical charts including radiology reports so misclassifi-
cation of subtype may have occurred because of lack of
full information. Furthermore, the TOAST criteria may
not be an accurate reflection of stroke mechanism;
although a superior classification system is not available
[23]. The mRS was retrospectively assessed at discharge by
data abstractors, a method that has not been previously
validated, but all abstractors were trained by the same
individual with training reinforced by a study neurologist.
The BASIC study population is over 50% Mexican Ameri-
can and thus differs from the general US population. Find-
ings from this study population may not be generalizable.
Several end points were assessed in our analysis and thus
readers are cautioned regarding the multiple compari-
sons, although the number of comparisons was not large
at five.
Conclusion
In our study population, we found that a positive family
history of stroke among a first degree relative was related
to ischemic stroke subtype and also to functional status at
discharge. More research is needed to understand whether
stroke subtype would be a useful selection criterion for
genetic association studies and to hypothesize about a
possible genetic link to recovery following ischemic
stroke.
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